Bumper Offer - Urjas oil Just @ Rs. 1
Turbovas Cv is a commercial drug that is prescribed in the form of Capsule. Other than this, Turbovas Cv has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Turbovas Cv depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Turbovas Cv also has some side effects, the most common being Chest Pain. Besides the aforementioned side effects, there are other adverse effects of Turbovas Cv as well, which are listed below. Usually, these side effects of Turbovas Cv go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Turbovas Cv has a Moderate effect for pregnant women and Mild effect on lactating mothers. In addition, Turbovas Cv's effects on the liver, heart and kidney are discussed below in the Turbovas Cv related warnings section.
Turbovas Cv can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Turbovas Cv in conditions like Kidney Disease, Hypothyroidism, Drug Allergy. Some other conditions that can be affected by Turbovas Cv are listed in the contraindications section below.
Additionally, Turbovas Cv may also adversely react with other medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Turbovas Cv is considered safe while driving, and is addictive.
Turbovas Cv is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Turbovas Cv is used -
Severe
Moderate
Mild
Common
Is the use of Turbovas Cv safe for pregnant women?
Turbovas CV can have harmful effects in pregnant women. If you experience any discomfort after using Turbovas CV, then discontinue the use and take your doctor's advice.
Is the use of Turbovas Cv safe during breastfeeding?
Breastfeeding women can take Turbovas CV as it bears very minor side effects for them.
What is the effect of Turbovas Cv on the Kidneys?
Turbovas CV rarely harms the kidneys.
What is the effect of Turbovas Cv on the Liver?
Turbovas CV may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Turbovas Cv on the Heart?
Turbovas CV is rarely harmful for the heart.
Turbovas Cv should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Turbovas Cv unless your doctor advises you to do so -
Is this Turbovas Cv habit forming or addictive?
Turbovas Cv is not addictive in nature.
Interaction between Food and Turbovas Cv
When consumed with certain foods, Turbovas Cv may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Turbovas Cv
Information about the interaction of Turbovas Cv and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Plavix (clopidogrel bisulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 630-631
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 335-336